Investigation of comorbidity, treatment resistance, severity, functional disability, QOL for psychiatric disorders.

Investigation of comorbidity, treatment resistance, severity, functional disability, QOL for psychiatric disorders. - Investigation of comorbidity, treatment resistance, severity, functional disability, QOL for psychiatric disorders.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035197

Enrollment

250

Registered

2018-12-11

Start date

2016-11-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive disorder, Persistent Depressive Disorder, Bipolar 1 disorder, Bipolar 2 Disorder, Panic Disorder, Agoraphobia, Social anxiety Disorder, Obsessive-Compulsive disorder, PTSD, Substance related disorder, Anorexia nervosa, Bulimia Nervosa, General anxiety disorder (DSM-5)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who started to be admitted to Nagoya City University Hospital (psychiatry, psychosomatic medicine). 2) Patients who were diagnosed Depressive disorder, Persistent Depressive Disorder, Bipolar 1 disorder, Bipolar 2 Disorder, Panic Disorder, Agoraphobia, Social anxiety Disorder, Obsessive-Compulsive disorder, PTSD, Substance related disorder, Anorexia nervosa, Bulimia Nervosa or General anxiety disorder by DSM-5.

Exclusion criteria

Exclusion criteria: 1) Patients who were diagnosed/ strongly suspected neurodevelopment disorders, schizophrenia spectrum and other psychotic disorders, neurocognitive disorders, manic episode, hypomanic episode, epilepsy or mental disorder due to medical condition by DSM-5 2) Patients who can't understand Japanese well. 3) Patients who had participated in this study. 4) Patients who were supposed to be hospitalized in 7 days. 5) Patients who their research doctor consider not suited.

Design outcomes

Primary

Measure	Time frame
On admission Interpersonal sensitivity measure: IPSM Ten Item Personality Inventory: TIPI Confidant Parental Bonding Instrument: PBI BDI-2 EQ5D Sheehan Disability Scale; SDS After 28day-42day at admission BDI-2 EQ5D Sheehan Disability Scale: SDS Interpersonal Sensitivity Measure; IPSM	—

Countries

Japan

Contacts

Public ContactRisa Imai

Nagoya City University Department of Psychiatry and Cognitive-Behavioral Medicine

imai.r.nagoya@gmail.com052-851-5511

Outcome results